Cargando…

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease

BACKGROUND: Management of motor complications (MC) represents a major challenge in the long-term treatment of Parkinson’s disease (PD) patients. In this context, the role of peripheral adaptive immunity may provide new insights, since neuroinflammatory mechanisms have been proved crucial in the dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contaldi, Elena, Magistrelli, Luca, Milner, Anna Vera, Cosentino, Marco, Marino, Franca, Comi, Cristoforo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150526/ https://www.ncbi.nlm.nih.gov/pubmed/33386815 http://dx.doi.org/10.3233/JPD-202417

Ejemplares similares

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
por: Comi, Cristoforo, et al.
Publicado: (2019)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
por: Alberio, Tiziana, et al.
Publicado: (2012)

The prevention of falls in patients with Parkinson’s disease with in-home monitoring using a wearable system: a pilot study protocol
por: Campani, Daiana, et al.
Publicado: (2022)

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
por: Storelli, Elisa, et al.
Publicado: (2019)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
por: Cappellano, Giuseppe, et al.
Publicado: (2020)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Factors associated with motor complications in Parkinson's disease
por: Kadastik‐Eerme, Liis, et al.
Publicado: (2017)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Safety of COVID-19 Vaccines: Spotlight on Neurological Complications
por: Tondo, Giacomo, et al.
Publicado: (2022)

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
por: Furgiuele, Alessia, et al.
Publicado: (2021)

Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
por: Cosentino, Marco, et al.
Publicado: (2022)

The spike hypothesis in vaccine-induced adverse effects: questions and answers
por: Cosentino, Marco, et al.
Publicado: (2022)

In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
por: Cosentino, Marco, et al.
Publicado: (2023)

Medical Management and Prevention of Motor Complications in Parkinson’s Disease
por: Aradi, Stephen D., et al.
Publicado: (2020)

Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals
por: Cosentino, Marco, et al.
Publicado: (2021)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

Gene polymorphisms and motor levodopa‐induced complications in Parkinson's disease
por: Michałowska, Małgorzata, et al.
Publicado: (2020)

A nationwide web-based survey of a sample of Italian community pharmacists’ perceptions and opinions about online sales of medicines and falsified drugs
por: Lombardo, Simona, et al.
Publicado: (2019)

Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series
por: Magistrelli, Luca, et al.
Publicado: (2021)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Efficacy and motor complications of original and generic levodopa in Parkinson’s disease treatment
por: Kasemsap, Narongrit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v4p1op52sc17n9nnc2ummra5mi